What is TAKHZYRO?
TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.
It is not known if TAKHZYRO is safe and effective in children under 12 years of age.